K. Hählen

5.5k citations

84 papers · 4.1k indexed · h-index 39

Impact in

Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Public Health, Environmental and Occupational Health top 0.5%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 38
- Acute Myeloid Leukemia Research 26
- Chronic Myeloid Leukemia Treatments 16
- Hematopoietic Stem Cell Transplantation 6
Genetics 23
- Chronic Lymphocytic Leukemia Research 18

Co-authors: A. Veerman Jacques J. M. van Dongen A Hagemeijer Herbert Hooijkaas J. Abels Gertjan J.L. Kaspers Auke Beishuizen Rob Pieters
Journals: Leukemia (13 papers)Blood (9 papers)Pediatric Research (4 papers)British Journal of Cancer (3 papers)European Journal of Cancer (3 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

K. Hählen

84 papers receiving 3.9k citations

Peers

Countries citing papers authored by K. Hählen

Since Specialization

Citations

This map shows the geographic impact of K. Hählen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Hählen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Hählen more than expected).

Fields of papers citing papers by K. Hählen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Hählen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Hählen. The network helps show where K. Hählen may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Hählen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Hählen Line = papers co-authored together K. Hählen links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Stability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples Leukemia ·Jacqueline Cloos, Bianca F. Goemans, Corine J. Hess, J W van Oostveen, Quinten Waisfisz, Sophie L. Corthals, Desiree De Lange, Nancy Boeckx, K. Hählen, Dirk Reinhardt, Ursula Creutzig, Gerrit Jan Schuurhuis, Ch. M. Zwaan, Gertjan J.L. Kaspers	2006	140
2	Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience Leukemia ·Ф В Малхозова, R. Maarten Egeler, A van der Does-van den Berg, Arleia Gomes de Sousa RIBEIRO, K. Hählen, Willem A. Kamps, A. Veerman, C. Michel Zwaan	2005	98
3	Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials Leukemia ·G Kardos, C. Michel Zwaan, Gertjan J.L. Kaspers, Jan‐Ragnar Haugstvedt, E. S. J. M. de Bont, A. Postma, J.P.M. Bökkerink, Ron S. Weening, A van der Does-van den Berg, Elisabeth R. van Wering, Arleia Gomes de Sousa RIBEIRO, K. Hählen	2005	37
4	Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL Leukemia ·忠一義永, Francisco Lorea Hernández, A Madrigali, W M Comans-Bitter, MJ Willemse, K. Hählen, WA Kamps, ER van Wering, Jacques J. M. van Dongen	2002	108
5	Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy Leukemia ·Ehrkesh Nurpeisov, YM Wiegers, A L Mutuli, K. Hählen, Jacques J. M. van Dongen, Herbert Hooijkaas	2000	59
6	Cross-lineage T cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease Leukemia ·Tomasz Szczepański, Auke Beishuizen, Carolina Flota-BaÃ±uelos, K. Hählen, ER van Wering, A Madrigali, G J Tibbe, Edgar H. Guevara Noel Tyler, Jacques J. M. van Dongen	1999	126
7	Bone mineral density in children with acute lymphoblastic leukaemia European Journal of Cancer ·Annemieke M. Boot, Marry M. van den Heuvel‐Eibrink, K. Hählen, E. P. Krenning, Sabine M.P.F. de Muinck Keizer‐Schrama	1999	56
8	Effects of interleukin 3, interleukin 7, and B-cell growth factor on proliferation and drug resistance in vitro in childhood acute lymphoblastic leukemia Annals of Hematology ·William Cisneros, Gertjan J.L. Kaspers, Rob Pieters, C. H. Van Zantwijk, GJ Broekema, K. Hählen, A. Veerman	1999	8
9	Cranial irradiation is the major cause of learning problems in children treated for leukemia and lymphoma: a comparative study Leukemia ·N. M Kiseleva, Anke de Groot, Jacques J. M. van Dongen, Martikainen Hannu, K. Hählen	1997	40
10	Interleukin-10 and Soluble Tumor Necrosis Factor Receptors in Cerebrospinal Fluid of Children with Bacterial Meningitis The Journal of Infectious Diseases ·René F. Kornelisse, H.F.J. Savelkoul, M. Sakat, Marja H. Suur, P. J. C. van der Straaten, Albert J. van der Heijden, R. N. Sukhai, K. Hählen, Herman J. Neijens, Rosa de Groot	1996	44
11	Impact of Childhood Leukemia on Family Planning Pediatric Hematology and Oncology ·J. E. W. M. Van Dongen-Melman, Anke de Groot, K. Hählen, Frank C. Verhulst	1995	7
12	Growth of children with Langerhans cell histiocytosis European Journal of Pediatrics ·Aad Hoek, Lihong Yin, R. Maarten Egeler, K. Hählen	1995	9
13	Obesity after Successful Treatment of Acute Lymphoblastic Leukemia in Childhood Pediatric Research ·J. E. W. M. Van Dongen-Melman, Anita C. S. Hokken‐Koelega, K. Hählen, Anke de Groot, Yongdeok Kim, R. Maarten Egeler	1995	115
14	Siblings of childhood cancer survivors: How does this “forgotten” group of children adjust after cessation of successful cancer treatment? European Journal of Cancer ·J. E. W. M. Van Dongen-Melman, Anke de Groot, K. Hählen, Frank C. Verhulst	1995	38
15	Parents of childhood cancer survivors: A qualitative analyses of late effects UvA-DARE (University of Amsterdam) ·M Elaine, F.J. van Zuuren, K. Hählen, F.C. Verhulst	1994	1
16	Specific sequelae after Fontan operation at mid- and long-term follow-up Journal of Thoracic and Cardiovascular Surgery ·A.H. Cromme-Dijkhuis, John Hess, K. Hählen, C M A Henkens, Margreet Th.E. Bink‐Boelkens, A Eygelaar, Egbert Bos	1993	135
17	Long-Term Effects of Treatment for Acute Lymphoblastic Leukemia with and without Cranial Irradiation on Growth and Puberty: A Comparative Study Pediatric Research ·Anita Hokken-Koelega, Narong Mulsri, K. Hählen, Theo Stijnen, John M. Pace, Stenvert L. S. Drop	1993	59
18	Cellular Drug Sensitivity of Immunophenotypic Subgroups of Childhood Acute Lymphoblastic Leukemia Recent results in cancer research ·Rob Pieters, Gertjan J.L. Kaspers, Elisabeth R. van Wering, D. R. Huismans, A. H. Loonen, K. Hählen, A. Veerman	1993	1
19	Dutch Childhood Leukemia Study Group: Early Results of Study ALL VI (1984–1988) Hämatologie und Bluttransfusion ·A. Veerman, K. Hählen, W. A. Kamps, Xi-Yue Xiong, G. A. M. de Vaan, Nabilah Anandri Dalhayat, John Huddleston, G. Solbu, Stefan Suciu	1990	27
20	Double Marker Analysis for Terminal Deoxynucleotidyl Transferase and Myeloid Antigens in Acute Nonlymphocytic Leukemia Patients and Healthy Subjects Hämatologie und Bluttransfusion ·Henk J Adriaansen, Herbert Hooijkaas, M. C. Kappers‐Klunne, K. Hählen, Mars B. vanʼt Veer, Jacques J. M. van Dongen	1990	14

About K. Hählen

K. Hählen is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Oncology, having authored 84 papers that have together received 4.1k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (57 papers), Acute Myeloid Leukemia Research (26 papers), Chronic Lymphocytic Leukemia Research (18 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Chronic Myeloid Leukemia Treatments (16 papers), Cancer therapeutics and mechanisms (6 papers), Hematopoietic Stem Cell Transplantation (6 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Hematology (2.1k citations), Public Health, Environmental and Occupational Health (2.4k citations), Genetics (583 citations), Pediatrics, Perinatology and Child Health (938 citations) and Oncology (612 citations). K. Hählen has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include A. Veerman, Jacques J. M. van Dongen, A Hagemeijer, Herbert Hooijkaas, J. Abels, Gertjan J.L. Kaspers, Auke Beishuizen, Rob Pieters, Elisabeth R. van Wering and ER van Wering. Their work appears in journals such as Leukemia, Blood, Pediatric Research, British Journal of Cancer and European Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact